Skip to main content

Trinity College Dublin, The University of Dublin

Menu Search


Trinity College Dublin By using this website you consent to the use of cookies in accordance with the Trinity cookie policy. For more information on cookies see our cookie policy.

      
Profile Photo

Dr. Dania Movia

Adjunct Assistant Professor (Radiation Therapy)
      
Profile Photo

Dr. Dania Movia

Adjunct Assistant Professor (Radiation Therapy)

 dmovia@tcd.ie

 


Dr. Dania Movia is a dynamic Assistant Professor in Biomedical & Health Services at the Department of Biology, Maynooth University. She also serves as Principal Investigator at the Kathleen Lonsdale Institute for Human Health Research, where her groundbreaking work continues to advance the respiratory research field. In addition, Dr Movia holds the position of Adjunct Assistant Professor at the Discipline of Radiation Therapy, Trinity College Dublin, Ireland, further solidifying her presence in the academic and research communities. Dr Movia's academic journey began with a degree in Chemistry and Pharmaceutical Technologies, which she earned from the University of Trieste, Italy, in 2007. She went on to obtain her PhD from Trinity College Dublin in 2012. Trinity College later conferred upon her a Special Purpose Certificate in Academic Practice in 2018, and a Master of Arts (jure officii) in 2023 as a recognition of her ongoing contributions to the College. A dedicated member of numerous esteemed professional organizations, Dr Movia plays a key role in shaping the future of cancer research and alternatives to animal testing. Her affiliations include the Irish Lung Cancer Alliance (ILCA), Cancer Trials Ireland, the European Association for Cancer Research (EACR), and the European Society for Alternatives to Animal Testing (EUSAAT), the European 3Rs Society that actively promotes the implementation of the 3Rs Principle (Reduce, Refine and Replace) in animal research. She also lends her expertise to the scientific advisory panels of Animal-Free Research UK and FRAME-UK and contributes to the COST Action CA21139 initiative - "3Rs Concepts to Improve the Quality of Biomedical Science (IMPROVE)." With over 50 peer-reviewed publications to her name, Dr. Movia is a prolific contributor to scientific literature. In her editorial roles, she has served as Guest Editor for Animals (MDPI) and Frontiers in Bioengineering and Biotechnology, and she co-edited the book Cancer Cell Culture in the renowned Methods in Molecular Biology series published by Springer Nature. This work, featuring contributions from 38 international experts, stands as a testament to her collaborative spirit and leadership in the field. She currently serves as an Associate Editor for Frontiers in Pharmacology, continuing to influence and guide cutting-edge research. Dr Movia's commitment to scientific excellence, her diverse roles, and her dedication to fostering innovation through sustainable animal-free research make her a leader in the biomedical field.
  Alternatives to Animal Testing   Biology   Biomaterials   Cellular Biology   Imaging Techniques   In vitro alternatives to animal studies   In vitro testing, trial methods   Lung cancer   Medicinal Chemistry   Nanochemistry   Nanomedicine   Nanotechnology   Pancreatic cancer   Physical Chemistry   Spectroscopy
Project Title
 Extracellular vesicles in Non-Small-Cell Lung Cancer - Finding allies among the enemies
From
2022
To
2026
Summary
Funding Agency
Science Foundation Ireland
Programme
SFI-IRC Pathway Programme
Project Title
 Developing novel inhaled bioengineered Extracellular Vesicle RNA based advanced therapeutics, delivered by tailored aerosol delivery technology for the treatment of lung cancer (INSPIRE)
From
2022
To
2025
Summary
Funding Agency
European Commission
Programme
HORIZON-HLTH-2021-TOOL-06
Project Title
 Towards a kinder yet impactful way to conduct lung cancer research
From
2022
To
2023
Summary
Funding Agency
School of Medicine, Trinity College Dublin
Programme
TCD MED Award
Project Title
 Risk Management of Biomaterials (BIORIMA)
From
2017
To
2022
Summary
Funding Agency
European Union
Programme
INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials
Project Title
 Pre-clinical models for predicting the toxicity, absorption and biodistribution of inhaled nanomaterials in humans
From
2018
To
2020
Summary
Funding Agency
Johns Hopkins University Center for Alternatives to Animal Testing (CAAT)
Programme
CAAT Award

Page 1 of 2
Details Date
Scientific Advisory Panel member, FRAME UK 2021
Scientific Advisory Panel member, Animal-Free Research UK. 2019
Topic Editor for the Frontiers in Bioengineering and Biotechnology journal (Topic: Use of 3D Models in Drug Development and Precision Medicine: Advances and Outlook). 2019
Review Editor, Predictive Toxicology, specialty section of the Frontiers in Pharmacology journal. 2021
Guest Editor, Animals (MDPI) journal - Topic title: Replacing Animal Testing in Research"A Scientific and Regulatory Perspective of Current Efforts Towards the 1R. 2021
Reviewer for several international scientific journals. A list is available at: http://www.webofscience.com/wos/author/record/T-6552-2018 Present
Language Skill Reading Skill Writing Skill Speaking
English Fluent Fluent Fluent
German Basic Basic Basic
Italian Fluent Fluent Fluent
Details Date From Date To
EACR (European Association for Cancer Research) membership 2018 Present
Irish Lung Cancer Alliance (ILCA) member 2021 Present
Cancer Trials Ireland membership 2022 Present
Soliman, M.G. and Trinh, D.N. and Ravagli, C. and Meleady, P. and Henry, M. and Movia, D. and Doumett, S. and Cappiello, L. and Prina-Mello, A. and Baldi, G. and Monopoli, M.P., Development of a fast and simple method for the isolation of superparamagnetic iron oxide nanoparticles protein corona from protein-rich matrices, Journal of Colloid and Interface Science, 659, 2024, p503-519 , Notes: [cited By 0], Journal Article, PUBLISHED  DOI
Ripoll-Viladomiu, I. and Prina-Mello, A. and Movia, D. and Marignol, L., Extracellular vesicles and the "six Rs" in radiotherapy, Cancer Treatment Reviews, 129, (102799), 2024, Review Article, PUBLISHED  DOI
Dania Movia and Adriele Prina-Mello*, Cancer Cell Culture Methods and Protocols, Methods in Molecular Biology, New York, Humana Press - Springer Nature, 2023, 1 - 2989pp, Book, PUBLISHED  URL
A Method for Culturing 3D Tumoroids of Lung Adenocarcinoma Cells at the Air-Liquid Interface in, 2023, pp173-178 , [Movia, D. and Prina-Mello, A.], Notes: [cited By 1], Book Chapter, PUBLISHED  DOI
Mullen, S. and Movia, D., The role of extracellular vesicles in non-small-cell lung cancer, the unknowns, and how new approach methodologies can support new knowledge generation in the field, European Journal of Pharmaceutical Sciences, 188, (106516), 2023, Notes: [cited By 1], Journal Article, PUBLISHED  DOI
Neuhaus W, Reininger-Gutmann B, Rinner B, Plasenzotti R, Wilflingseder D, De Kock J, Vanhaecke T, Rogiers V, Jírová D, Kejlová K, Knudsen LE, Spielmann H, The Current Status and Work of Three Rs Centres and Platforms in Europe., Alternatives to laboratory animals : ATLA, 2022, Journal Article, PUBLISHED  DOI
Neuhaus W, Reininger-Gutmann B, Rinner B, Plasenzotti R, Wilflingseder D, De Kock J, Vanhaecke T, Rogiers V, Jírová D, Kejlová K, Knudsen LE, Nielsen RN, Kleuser B, Kral V, Thöne-Reineke C, Hartung T, Pallocca G, Leist M, Hippenstiel S, Lang A, Retter I, Krämer S, Jedlicka P, Ameli K, Fritsche E, Tigges J, Buettner M, Bleich A, Baumgart N, Baumgart J, Meinhardt MW, Spanagel R, Chourbaji S, Kränzlin B, Seeger B, von Köckritz-Blickwede M, Sánchez-Morgado JM, Galligioni V, Ruiz-Pérez D, Movia D, Prina-Mello A, Ahluwalia A, Chiono V, Gutleb AC, Schmit M, van Golen B, van Weereld L, Kienhuis A, van Oort E, van der Valk J, Smith A, Roszak J, St"pnik M, Soba"ska Z, Olsson IAS, Franco NH, Sevastre B, Kandarova H, Capdevila S, Johansson J, Cederroth CR, Sandström J, Ragan I, Bubalo N, Spielmann H., The Rise of Three Rs Centres and Platforms in Europe., Alternatives to laboratory animals : ATLA, 50, (2), 2022, p90-120 , Journal Article, PUBLISHED  DOI
Galligioni, V. and Movia, D. and Ruiz-Perez, D. and Sanchez-Morgado, J.M. and Prina-Mello, A., The Case for Modernizing Biomedical Research in Ireland through the Creation of An Irish 3Rs Centre, Animals, 12, (9), 2022, Notes: [cited By 0], Journal Article, PUBLISHED  DOI
Tutty, M.A. and Movia, D. and Prina-Mello, A., Three-dimensional (3D) liver cell models - a tool for bridging the gap between animal studies and clinical trials when screening liver accumulation and toxicity of nanobiomaterials, Drug Delivery and Translational Research, 2022, Review Article, PUBLISHED  DOI
Special Issue "Replacing Animal Testing in Research"A Scientific and Regulatory Perspective of Current Efforts Towards the 1R", Animals (MDPI), 2021-2022, Editorial Board, PUBLISHED
  

Page 1 of 6
Susan Dekkers, Agnes G Oomen, Eric AJ Bleeker, Rob J Vandebriel, Christian Micheletti, Joan Cabellos, Gemma Janer, Natalia Fuentes, Socorro Vázquez-Campos, Teresa Borges, Maria João Silva, Adriele Prina-Mello, Dania Movia, Fabrice Nesslany, Ana Ribeiro, Paulo Emílio Leite, Monique Groenewold, Flemming R Cassee, Adrienne JAM Sips, Aart Dijkzeul, Tom van Teunenbroek, Susan WP Wijnhoven, NANoREG Deliverable D 5.8-Decision tree for risk assessment of MNMs , 2016, Report, PUBLISHED
Gavigan-Imedio J.D., Movia D., Volkov Y., Prina-Mello A., Nanomedicine translational oncology: a perspective to cancer treatment, EuroNanoForum, Dublin, Ireland, June 2013, 2013, Notes: [Poster presentation], Oral Presentation, PRESENTED
Movia D., Del Canto E., Giordani S., Purified and Oxidized SWNTs: potential NIR fluorescence probes for molecular imaging, ChemOnTubes 2010, Arcachon, France, 11-15/04/2010, 2010, Notes: [Poster presentation], Oral Presentation, PRESENTED

  


Award Date
Research Award in recognition for the publication of an internationally peer-reviewed publication of the highest quality. 2012
Best Material Science Poster, 33rd Annual Microscopy Society of Ireland (MSI) meeting 2009
Paper of the Year 2012, Society of Toxicology Board 2012
Dr Dania Movia is a passionate advocate for transforming biomedical research by reducing and replacing animal testing through sustainable research and the education of young scientists on new preclinical technologies. Her work is driven by a commitment to advancing science in a more sustainable direction, focusing on the development of New Approach Methodologies (NAMs) designed to replace animal studies in the fields of lung cancer and lung toxicity research. As the founder and lead of the Humane Biomedical Research Group, Dr Movia has established Ireland's first wet-lab dedicated entirely to animal-free respiratory research. The lab's groundbreaking mission is to accelerate the translation of preclinical data into effective clinical treatments for patients with respiratory diseases - without the use of animal experimentation. Through this pioneering initiative, Dr Movia aims to foster long-term therapeutic responses, ensuring that innovations in research directly benefit patient care. Her efforts have garnered international recognition and substantial financial support, with over €23 million in research funding, including more than €2 million allocated directly to her as Principal Investigator. This funding comes from a wide array of prestigious national, European, and international organizations, including the Irish Research Council, Science Foundation Ireland, the Johns Hopkins Center for Alternatives to Animal Testing, Animal-Free Research UK, and the European Commission. Dr Movia's leadership in humane science is not only advancing the field but is also shaping the future of biomedical research by setting a new standard for ethical, innovative, and sustainable approaches to disease treatment. Research areas: 1. In vitro New Approach Methodologies (NAMs) 2. Alternatives to animal research and 3Rs principle 3. Lung cancer research 4. Inhalation toxicology 5. Oncological nanomedicine 6. Risk assessment of nanomaterials 7. Nanotechnology An up-to-date list of her publications can be found at: https://scholar.google.com/citations?user=T60uEacAAAAJ&hl=en&oi=ao